[go: up one dir, main page]

WO2007042048A3 - Methode amelioree de preparation de risedronate sodique cristallin - Google Patents

Methode amelioree de preparation de risedronate sodique cristallin Download PDF

Info

Publication number
WO2007042048A3
WO2007042048A3 PCT/DK2006/050054 DK2006050054W WO2007042048A3 WO 2007042048 A3 WO2007042048 A3 WO 2007042048A3 DK 2006050054 W DK2006050054 W DK 2006050054W WO 2007042048 A3 WO2007042048 A3 WO 2007042048A3
Authority
WO
WIPO (PCT)
Prior art keywords
sodium risedronate
new
preparing crystalline
crystalline sodium
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2006/050054
Other languages
English (en)
Other versions
WO2007042048A2 (fr
Inventor
Herbert Fritz Preikschat
Erik Fischer
Frederick Beck
Jacob Bennekou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AS
Original Assignee
Sandoz AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05388086A external-priority patent/EP1775302A1/fr
Application filed by Sandoz AS filed Critical Sandoz AS
Publication of WO2007042048A2 publication Critical patent/WO2007042048A2/fr
Publication of WO2007042048A3 publication Critical patent/WO2007042048A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne une nouvelle méthode de préparation de risédronate sodique cristallin, mise en oeuvre dans des conditions telles que la disponibilité d'eau est strictement limitée. L'invention concerne également de nouvelles formes du risédronate sodique préparées selon la nouvelle méthode de l'invention. Ces nouvelles formes du risédronate sodique sont utiles pour la préparation de compositions pharmaceutiques destinées au traitement de maladies osseuses et du métabolisme calcique.
PCT/DK2006/050054 2005-10-11 2006-10-05 Methode amelioree de preparation de risedronate sodique cristallin Ceased WO2007042048A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72556605P 2005-10-11 2005-10-11
EP05388086A EP1775302A1 (fr) 2005-10-11 2005-10-11 Méthode pour la préparation de risedronate de sodium cristallin
EP05388086.0 2005-10-11
US60/725,566 2005-10-11

Publications (2)

Publication Number Publication Date
WO2007042048A2 WO2007042048A2 (fr) 2007-04-19
WO2007042048A3 true WO2007042048A3 (fr) 2007-06-07

Family

ID=37575193

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2006/050054 Ceased WO2007042048A2 (fr) 2005-10-11 2006-10-05 Methode amelioree de preparation de risedronate sodique cristallin

Country Status (1)

Country Link
WO (1) WO2007042048A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5052816B2 (ja) * 2006-04-26 2012-10-17 株式会社パーマケム・アジア ３−ピリジル−１−ヒドロキシエチリデン−１、１−ビスホスホン酸ナトリウム塩２．５水和物ａ型結晶の製造方法
JP2009536639A (ja) 2006-05-11 2009-10-15 アイエヌディー−スイフト ラボラトリーズ リミテッド 純リセドロン酸または塩を調製するための方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020002282A1 (en) * 2000-02-01 2002-01-03 Cazer Frederick Dana Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US20030195170A1 (en) * 2002-04-11 2003-10-16 Judith Aronhime Novel polymorphs and pseudopolymorphs of risedronate sodium
WO2004037252A1 (fr) * 2002-10-25 2004-05-06 Zentiva, A.S. Nouvelle forme cristalline de sel de sodium d'acide 3-pyridyl-1-hydroxyethylidene-1,1-biphosphonique
WO2005075487A1 (fr) * 2004-02-05 2005-08-18 Zentiva, A.S. Forme cristalline du risedronate monosodique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020002282A1 (en) * 2000-02-01 2002-01-03 Cazer Frederick Dana Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US20030195170A1 (en) * 2002-04-11 2003-10-16 Judith Aronhime Novel polymorphs and pseudopolymorphs of risedronate sodium
WO2004037252A1 (fr) * 2002-10-25 2004-05-06 Zentiva, A.S. Nouvelle forme cristalline de sel de sodium d'acide 3-pyridyl-1-hydroxyethylidene-1,1-biphosphonique
WO2005075487A1 (fr) * 2004-02-05 2005-08-18 Zentiva, A.S. Forme cristalline du risedronate monosodique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
REDMAN-FUREY, NANCY ET AL: "Structural and analytical characterization of three hydrates and an anhydrate form of risedronate Structural and analytical characterization of three hydrates and an anhydrate form of risedronate", JOURNAL OF PHARMACEUTICAL SCIENCES , 94(4), 893-911 CODEN: JPMSAE; ISSN: 0022-3549, April 2005 (2005-04-01), XP002366745 *

Also Published As

Publication number Publication date
WO2007042048A2 (fr) 2007-04-19

Similar Documents

Publication Publication Date Title
WO2005005447A3 (fr) Formes cristallines d'acide zoledronique, formes cristallines de sel de sodium de zoledronate, sel de sodium de zoledronate amorphe et procedes de preparation de ceux-ci
WO2006024024A3 (fr) Sodium d'ibandronate solide cristallin et ses procedes de preparation
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
TW200621776A (en) Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
WO2008076392A3 (fr) Composés utilisables en tant qu'inhibiteurs de protéines kinases
WO2008112651A3 (fr) Aminopyrimidines utiles en tant qu'inhibiteurs des protéines kinases
WO2010131922A3 (fr) Composé amide, procédé de préparation de celui-ci et composition pharmaceutique le comprenant
WO2004050620A3 (fr) Derives d'acides succinique et glutarique et leurs analogues utilises comme inhibiteurs de phex
MX2009005413A (es) Formas cristalinas del acido zoledronico.
WO2010001257A3 (fr) Nouvelles formes à l’état solide de laquinimod et son sel de sodium
WO2007025005A3 (fr) Formulations de nalbuphine a liberation prolongee
PL1745136T3 (pl) Sposób enzymatycznego wytwarzania kwasu (S)-3-cyjano-5-metyloheksanowego
WO2010034497A3 (fr) Cinacalcet compacté
WO2011023367A3 (fr) Promédicaments bisphosphonates
WO2006074951A3 (fr) Composition d'olanzapine ou de donepezil a desintegration orale
WO2007044950A3 (fr) Formes cristallines de docetaxel et leurs processus de preparation
WO2006029081A3 (fr) Conjugues nucleoside-lipide, leur procede de preparation, et leurs utilisations
WO2006042034A8 (fr) Sel et ses formes cristallines d'un medicament
WO2006057011A3 (fr) Composition et procede de guerison osseuse
WO2007055885A3 (fr) Compositions pharmaceutiques de gallium et procedes
WO2010006904A3 (fr) Nouvelles formes cristallines du rabéprazole sodique
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
TW200833371A (en) Process for solid formulations
WO2010033981A3 (fr) 5-azaindole bisphosphonates
WO2007042048A3 (fr) Methode amelioree de preparation de risedronate sodique cristallin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06791491

Country of ref document: EP

Kind code of ref document: A2